World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
109
Citations
37242
World Ranking
5832
National Ranking
3131

Overview

Mark Krailo is affiliated with the University of Southern California in the United States and has a substantial record of research publications within medicine and related fields. Their work spans several subfields, including pulmonary and respiratory medicine, surgery, neurology, cancer research, and molecular biology.

They have contributed extensively to topics such as sarcoma diagnosis and treatment, neuroblastoma research and treatments, testicular diseases and treatments, cancer genomics and diagnostics, lymphoma diagnosis and treatment, glioma diagnosis and treatment, and hepatocellular carcinoma treatment and prognosis.

Mark Krailo's recent publications include:

  • Efficacy of High-Dose Chemotherapy and Three-Dimensional Conformal Radiation for Atypical Teratoid/Rhabdoid Tumor: A Report From the Children's Oncology Group Trial ACNS0333, 2020, Journal of Clinical Oncology
  • Treatment of Pediatric Adrenocortical Carcinoma With Surgery, Retroperitoneal Lymph Node Dissection, and Chemotherapy: The Children's Oncology Group ARAR0332 Protocol, 2021, Journal of Clinical Oncology
  • Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group, 2023, Journal of Clinical Oncology
  • Temozolomide with irinotecan versus temozolomide, irinotecan plus bevacizumab for recurrent medulloblastoma of childhood: Report of a COG randomized Phase II screening trial, 2021, Pediatric Blood & Cancer
  • The importance of age as prognostic factor for the outcome of patients with hepatoblastoma: Analysis from the Children's Hepatic tumors International Collaboration (CHIC) database, 2020, Pediatric Blood & Cancer

Frequent co-authors collaborating with Mark Krailo include:

  • Katherine A. Janeway
  • Allen Buxton
  • Steven G. DuBois
  • Damon R. Reed
  • Richard Görlick

Their research has been published predominantly in the following venues:

  • Journal of Clinical Oncology
  • Pediatric Blood & Cancer
  • European Journal of Cancer
  • Neuro-Oncology
  • Journal of Pediatric Surgery

Mark Krailo's scholarly contributions cover a broad range of medical sciences, bridging clinical treatment approaches with molecular and genetic insights, especially within oncology and pediatric diseases. Their work reflects involvement in multi-institutional clinical trials and collaborations within the Children's Oncology Group and other research consortia.

Best Publications

  • Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone.

    Holcombe E Grier;Mark D Krailo;Nancy J Tarbell;Michael P Link

  • ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer

    M C Pike;M D Krailo;B E Henderson;J T Casagrande

  • Osteosarcoma: The Addition of Muramyl Tripeptide to Chemotherapy Improves Overall Survival—A Report From the Children's Oncology Group

    Paul A. Meyers;Cindy L. Schwartz;Mark D. Krailo;John H. Healey

  • Osteosarcoma: A Randomized, Prospective Trial of the Addition of Ifosfamide and/or Muramyl Tripeptide to Cisplatin, Doxorubicin, and High-Dose Methotrexate

    Paul A. Meyers;Cindy L. Schwartz;Mark Krailo;Eugenie S. Kleinerman

  • The role of adjuvant chemotherapy following cystectomy for invasive bladder cancer : a prospective comparative trial

    Donald G. Skinner;John R. Daniels;Christy A. Russell;Gary Lieskovsky

  • Randomized Controlled Trial of Interval-Compressed Chemotherapy for the Treatment of Localized Ewing Sarcoma: A Report From the Children's Oncology Group

    Richard B. Womer;Daniel C. West;Mark D. Krailo;Paul S. Dickman

  • Treatment of nonmetastatic osteosarcoma of the extremity with preoperative and postoperative chemotherapy: a report from the Children's Cancer Group.

    A J Provisor;L J Ettinger;J B Nachman;M D Krailo

  • Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial

    Neyssa M Marina;Sigbjørn Smeland;Stefan S Bielack;Mark Bernstein

  • Survival and prognosis with osteosarcoma: outcomes in more than 2000 patients in the EURAMOS-1 (European and American Osteosarcoma Study) cohort

    Sigbjørn Smeland;Stefan S. Bielack;Jeremy Whelan;Mark Bernstein

  • Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial

    Stefan S. Bielack;Sigbjørn Smeland;Jeremy S. Whelan;Neyssa Marina

  • Do regular ovulatory cycles increase breast cancer risk

    Brian E. Henderson;Ronald K. Ross;Howard L. Judd;Mark D. Krailo

  • BREAST CANCER IN YOUNG WOMEN AND USE OF ORAL CONTRACEPTIVES: POSSIBLE MODIFYING EFFECT OF FORMULATION AND AGE AT USE

    M.C. Pike;M.D. Krailo;B.E. Henderson;A. Duke

  • Randomized Comparison of Cisplatin/Vincristine/Fluorouracil and Cisplatin/Continuous Infusion Doxorubicin for Treatment of Pediatric Hepatoblastoma: A Report From the Children’s Cancer Group and the Pediatric Oncology Group

    Jorge A. Ortega;Edwin C. Douglass;James H. Feusner;Marleta Reynolds

  • The effect of compliance with treatment on survival among patients with hematologic malignancies.

    J L Richardson;D R Shelton;M Krailo;A M Levine

  • Dose-intensified compared with standard chemotherapy for nonmetastatic ewing sarcoma family of tumors: A children's oncology group study

    Linda Granowetter;Richard Womer;Meenakshi Devidas;Mark Krailo

  • Phase II Study of Nelarabine (compound 506U78) in Children and Young Adults With Refractory T-Cell Malignancies: A Report From the Children’s Oncology Group

    Stacey L. Berg;Susan M. Blaney;Meenakshi Devidas;Tom A. Lampkin

  • Risk-stratified staging in paediatric hepatoblastoma: a unified analysis from the Children's Hepatic tumors International Collaboration

    Rebecka L Meyers;Rudolf Maibach;Eiso Hiyama;Beate Häberle

  • Secondary leukemia or myelodysplastic syndrome after treatment with epipodophyllotoxins.

    Malcolm A. Smith;Lawrence Rubinstein;James R. Anderson;Diane Arthur

  • Progress in Childhood Cancer: 50 Years of Research Collaboration, A Report from the Children's Oncology Group

    Maura O'Leary;Mark Krailo;James R. Anderson;Gregory H. Reaman

  • Breast Cancer in Young Women and Use of Oral Contraceptives: Possible Modifying Effect of Formulation and Age At Use

    M. C. Pike;B. E. Henderson;M. D. Krailo;A. Duke

Frequent Co-Authors

Richard Gorlick
Richard Gorlick The University of Texas MD Anderson Cancer Center
Peter C. Adamson
Peter C. Adamson Children's Hospital of Philadelphia
Holcombe E. Grier
Holcombe E. Grier Harvard University
Paul A. Meyers
Paul A. Meyers Memorial Sloan Kettering Cancer Center
Susan M. Blaney
Susan M. Blaney Baylor College of Medicine
Mark C. Gebhardt
Mark C. Gebhardt Harvard Medical School
Carlos Rodriguez-Galindo
Carlos Rodriguez-Galindo St. Jude Children's Research Hospital
Frederick J. Rescorla
Frederick J. Rescorla Indiana University
John H. Healey
John H. Healey Memorial Sloan Kettering Cancer Center
Stephen L. Lessnick
Stephen L. Lessnick Nationwide Children's Hospital

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine goes beyond becoming a doctor. Many students consider related fields that support the healthcare system and offer strong job prospects. Online degrees make it easier than ever to balance studies with your current commitments, whether you are looking to advance your career or switch fields.

For those interested in mental health, online msn pmhnp programs can lead to rewarding roles as psychiatric nurse practitioners. If leadership or management in healthcare appeals to you, an affordable mha online can set you on the pathway to becoming a healthcare administrator.

Concerned about costs? There are options like the cheapest online health science degree, which allows you to start your journey in healthcare without financial strain. For advanced nursing practice, check out the least expensive dnp programs to boost your qualifications for more specialized roles.

These online programs open up flexible career pathways in the fast-evolving world of healthcare—offering more ways to make a difference and shape your future, even outside of traditional medical school paths.

Best Scientists Citing Mark Krailo

Trending Scientists